COMPUTED DESCRIPTORS
| Molecular Weight | 1037.2 g/mol |
|---|---|
| XLogP3 | -2.7 |
| Hydrogen Bond Donor Count | 13 |
| Hydrogen Bond Acceptor Count | 17 |
| Rotatable Bond Count | 29 |
| Exact Mass | 1036.48993280 g/mol |
| Monoisotopic Mass | 1036.48993280 g/mol |
| Topological Polar Surface Area | 420 Ų |
| Heavy Atom Count | 72 |
| Formal Charge | 0 |
| Complexity | 1920 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
Reltecimod is under investigation in clinical trial NCT02469857 (Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections).